Cryo-Cell International, Inc. (CCEL)

CIK 0000862692 · Healthcare · Medical Care Facilities

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
Latest Q2-2026 —
Q1-2026 —
Latest FY-2025 —
Q3-2025 —
Q2-2025 —
Q1-2025 —
FY-2024 8-K (2024-10-17) · 99.1
Q3-2024
Q3-2024 —
Q2-2024 —
Q1-2024 —
FY-2023 —
Q3-2023 —

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Cover Page
Statements
Consolidated Balance Sheets
Consolidated Balance Sheets (P)
Consolidated Statements of Income
—
Consolidated Statements of Operations
—
Consolidated Statements of Cash Flows
Consolidated Statements of Stockholders' Deficit
—
Consolidated Statements of Stockholders' Equity (deficit)
—
Consolidated Statements of Stockholders' Deficit (P)
—
Consolidated Statements of Stockholders' Equity (deficit) (P)
—
Notes
Accrued Expenses
—
Allowance For Doubtful Accounts
—
Commitments and Contingencies
Cybersecurity Risk Management, Strategy, and Governance
—
Description of Business and Summary of Significant Accounting Policies
—
Description of Business, Basis of Presentation and Significant Accounting Policies
—
Income Per Common Share
—
Income Taxes
—
Insider Trading Arrangements
Insider Trading Policies and Procedures
—
Intangible Assets
Inventory
Leases
License Agreement With Duke
License Agreements
Note Payable
Pay Vs Performance Disclosure
Property and Equipment
—
Related Party Transactions
—
Retirement Plan
—
Revenue Sharing Agreements ("rsas")
—
Segment Reporting
Share Repurchase Plan
Stockholders' Equity
Subsequent Event
—